Mary Beth Muench-Holum

Mary Beth Muench-Holum is an experienced professional in the field of clinical operations, with a background in gene therapy, immuno-oncology, and pharmaceutical development. Mary Beth has held various leadership roles in companies such as NeoImmuneTech, Novartis Gene Therapies, Abbott, and Astellas Pharma. Mary Beth has a Bachelor of Science in Chemistry from Loras College, as well as Master's degrees in Pharmacology from Loyola University Chicago and Loyola University Stritch School of Medicine Graduate Program.